2026 ASH®
Annual Meeting & Exposition December 12-15, 2026 ▪ New Orleans, Louisiana

Paper Details

Abstracts, authors, affiliations, and disclosures.

Saturday, December 12, 2026
05:30 p.m. - 07:30 p.m.
MCCNO - Hall F
Technology and Procedures, Omics Technologies, Pathology, Bioinformatics, Computational Biology, Profiling, Treatment Considerations, Combination Therapy, Drug Development, Biological Therapies, Natural Killer (NK) Cell Therapies, Transplantation, Vaccines, Artificial Intelligence (AI), Machine Learning, Biological Processes, Pathogenesis, Genomics, Hematopoiesis, Immune Mechanism, Molecular Biology, Diseases, Bleeding and Clotting, Platelet Disorders, Myeloid Malignancies, Acute Myeloid Malignancies, Chronic Myeloid Malignancies, Research, Fundamental Science, AML, Translational Research, MPN, CML, Clinical Research, Clinical Trials, Study Population, Human, Adult, Animal Model
PAPER

1958 Spatial mapping of bone marrow niche reveals subtype-specific immune remodeling in MPN

Honghao Bi, MD, PhD, Wenjie Cai2, Pan Wang, PhD3, Ching Man Wai4, Inci Aydemir, MD5, Johanna Melo-Cardenas, PhD6, Peng Ji, MD, PhD7
1 Northwestern University, Chicago, Illinois, United States, Northwestern University, Feinberg School of Medicine, Chicago, Illinois, United States
2 Northwestern University, Chicago, Illinois, United States, Northwestern University, Feinberg School of Medicine, Chicago, Illinois, United States
3 Northwestern University, Chicago, Illinois, United States, Northwestern University, Feinberg School of Medicine, Chicago, Illinois, United States
4 Northwestern University, Chicago, Illinois, United States
5 Northwestern University, Chicago, Illinois, United States, Northwestern University, Feinberg School of Medicine, Chicago, Illinois, United States
6 Northwestern University, Chicago, Illinois, United States, Northwestern University, Feinberg School of Medicine, Chicago, Illinois, United States
7 Northwestern University, Chicago, Illinois, United States, Northwestern University, Feinberg School of Medicine, Chicago, Illinois, United States

Myeloproliferative neoplasms (MPNs) are caused by genetic mutations in hematopoietic cells that drive overproduction of blood cells. Beyond their cell-intrinsic effects, mutant cells actively remodel the bone marrow (BM) niche, but the spatial organization of this process remains poorly understood.

Here, we directly examined this spatial dimension using two complementary spatial transcriptomic platforms, Xenium 5K and Visium HD, on BM clot biopsies from 19 MPN patients (6 polycythemia vera [PV], 5 essential thrombocythemia [ET], 6 primary myelofibrosis [PMF], and 2 chronic myeloid leukemia [CML]) and 7 normal controls. We further designed customized probes to detect patient-specific mutations identified by clinical NGS panel testing, allowing us to pinpoint mutant cells within their spatial context and map how they remodel the niche around them. Data were processed using the standard 10x pipelines, and cells were annotated using Binary-SPA with a bone marrow marker set covering all major cell types. Annotation accuracy was validated on adjacent slide using COMET analysis with antibodies targeting corresponding cell marker proteins.

This analysis revealed spatially organized niches in normal human bone marrow, characterized by strong homotypic clustering, with cells of the same type tending to co-localize rather than intermix. This organization was disrupted in MPN, where different cell types showed increased spatial mixing.

To define how mutant cells disrupt niche organization, we adapted NicheCompass, a machine learning-based niche analysis tool, for BM-specific analysis by expanding its gene-program database to include CollecTRI, Reactome, and customized BM- and MPN-related programs in addition to the built-in OmniPath and MEBOCOST resources. Data from all 26 samples were jointly used for model training and constructing the gene-program-based latent space. Analysis of this latent space revealed significantly increased activity of programs associated with local immune signaling, altered hematopoietic differentiation and cell-state regulation, epigenetic remodeling, and altered redox and metabolic states within the JAK2V617F-mutant cell niche. These findings demonstrate that JAK2V617F-mutant cells actively reshape the bone marrow microenvironment.

We then expanded the enrichment analysis radially outward from JAK2V617F-mutant cells, examining concentric enrichment bands surrounding the mutant niche. The inner band was enriched for T cell activation signals, while the outer band showed enrichment of immune cell recruitment signals, suggesting that JAK2V617F-mutant cells actively provoke an immune response within the bone marrow. In parallel, we observed increased enrichment of HSPC-related gene programs in the inner layer, with the KLF1 gene program, a key regulator of megakaryocyte and erythroid differentiation, enriched in the outer layer. Together, these findings reveal a dynamic spatial interplay in MPN bone marrow, in which JAK2V617F-mutant cells establish their own niche while simultaneously engaging immune responses from the surrounding marrow.

Independent of NicheCompass, cell-type composition analysis using Binary-SPA corroborated these gene-program findings. Across all samples, macrophages were consistently enriched within the approximately 100-µm neighborhood represented by kNN hops 1–3. Within the immediate niche, defined as a 50 µm radius around JAK2V617F-mutant cells, we observed a significant enrichment of T cells. Notably, the pattern of T-cell remodeling varied by MPN subtype. ET samples showed the strongest enrichment of both CD4+ and CD8+ T cells around JAK2V617F-mutant cells. PV samples exhibited intermediate CD4+ T-cell enrichment, greater than that observed in PMF but lower than in ET, whereas CD8+ T-cell enrichment was comparable between PV and PMF. These findings suggest that subtype-specific spatial immune interactions may contribute to distinct disease trajectories across the MPN spectrum.

Based on these findings, we propose a new spatial model of MPN pathogenesis: mutant cells establish a self-supporting niche that drives their own proliferation and differentiation, while simultaneously triggering a macrophage and T cell response from the surrounding bone marrow. This immune response then infiltrates and engages the mutant niche, and the specific composition of these responses plays a key role in determining MPN phenotype.

Honghao Bi, MD, PhD: No relevant conflicts of interest to declare.